TTR and amyloidosis: The Transthyretin Amyloidosis Outcomes Survey (THAOS; NCT00628745) is a global, longitudinal observational registry study including patients with ATTR amyloidosis and asymptomatic TTR mutation carriers between 2007 and 2023 [5].